Safety and efficacy of dexmedetomidine vs ketamine vs midazolam combined with propofol in gastrointestinal endoscopy for cancer patients: A randomized double-blinded trial

References

• Codipilly DC, Qin Y, Dawsey SM, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88(3):413–426. doi: 10.1016/j.gie.2018.04.2352
   PubMed Web of Science ®Google Scholar
• Abu-Sbeih H, Ali FS, Coronel E, et al. Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia. Gastrointest Endosc. 2019;89(5):937–949. doi: 10.1016/j.gie.2018.12.004
   PubMed Web of Science ®Google Scholar
• Mandal M. Opioids as co-induction agents - the pros and cons. Int J Crit Illn Inj Sci. 2017;7(2):77–78. doi: 10.4103/IJCIIS.IJCIIS_25_17
   PubMedGoogle Scholar
• dos Santos ME L, Maluf-Filho F, Chaves DM, et al. Deep sedation during gastrointestinal endoscopy: propofol-fentanyl and midazolam-fentanyl regimens. World J Gastroenterol. 2013;19(22):3439–3446. doi: 10.3748/wjg.v19.i22.3439
   PubMed Web of Science ®Google Scholar
• Delgado AAA, de Moura DTH, Ribeiro IB, et al. Propofol vs traditional sedatives for sedation in endoscopy: a systematic review and meta-analysis. World J Gastrointest Endosc. 2019;11(11):573–588. doi: 10.4253/wjge.v11.i12.573
   PubMed Web of Science ®Google Scholar
• Amer AM, Youssef AM, El-Ozairy HS, et al. Propofol-cetamina versus dexmedetomidina-cetamina para sedação durante endoscopia digestiva alta em pacientes pediátricos: estudo clínico randomizado. Braz J Anesthesiol. 2020;70(6):620–626. doi: 10.1016/j.bjan.2020.08.005
   PubMedGoogle Scholar
• Yi SY, Shin JE. Midazolam for patients undergoing upper gastrointestinal endoscopy: a prospective, single-blind and randomized Study to determine the appropriate amount and time of initiation of endoscopy. J Gastroenterol Hepatol. 2005;20(12):1873–1879. doi: 10.1111/j.1440-1746.2004.04081.x
   PubMed Web of Science ®Google Scholar
• Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7(4):221–226. doi: 10.1097/00075198-200108000-00002
   PubMedGoogle Scholar
• Tekeli AE, Oğuz AK, Tunçdemir YE, et al. Comparison of dexmedetomidine-propofol and ketamine-propofol administration during sedation-guided upper gastrointestinal system endoscopy. Medicine (Baltimore). 2020;99(49):23–31. doi: 10.1097/MD.0000000000023317
   Web of Science ®Google Scholar
• Kohtala S. Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73(2):323–345. doi: 10.1007/s43440-021-00232-4
   PubMed Web of Science ®Google Scholar
• Himmelseher S, Durieux ME, Weiskopf R. Ketamine for perioperative pain management. Anesthesiology. 2005;102(1):211–220. doi: 10.1097/00000542-200501000-00030
   PubMed Web of Science ®Google Scholar
• Bachula L, Kumar SS, Shiva P. A comparative study of intravenous infusion of ketamine-propofol and ketamine-dexmedetomidine for deep sedation and analgesia in pediatric patients undergoing day care surgeries at niloufer hospital. J Cell Mol Anesth. 2018;8:48–60.
   Google Scholar
• Edelson JC, Edelson CV, Rockey DC, et al. Randomized controlled trial of ketamine and moderate sedation for outpatient endoscopy in adults. Mil Med. 2022. doi:10.1093/milmed/usac183.
   PubMed Web of Science ®Google Scholar
• Nishizawa T, Suzuki H, Sagara S, et al. Dexmedetomidine versus midazolam for gastrointestinal endoscopy: a meta-analysis. Dig Endosc. 2015;27(1):8–15. doi: 10.1111/den.12399
   PubMed Web of Science ®Google Scholar
• Samson S, George SK, Vinoth B, et al. Comparison of dexmedetomidine, midazolam, and propofol as an optimal sedative for upper gastrointestinal endoscopy: a randomized controlled trial. J Dig Endosc. 2014;5(02):051–7. doi: 10.4103/0976-5042.144826
   Google Scholar
• Elzohry A, Ali A, Shehata M. Ketamine versus dexmedetomidine as adjunct agent to propofol for sedation during endoscopic retrograde cholangiopancreatography (ERCP). Integr Anesthesiol. 2018;1:01–7.
   Google Scholar
• Guo Y, Zhang H, Feng X, et al. A retrospective study of RISK factors for cardiopulmonary events during propofol-mediated gastrointestinal endoscopy in patients aged over 70 years. Middle East J Anaesthesiol. 2012;21(4):505–511.
   PubMedGoogle Scholar
• Molina-Infante J, Dueñas-Sadornil C, Mateos-Rodriguez JM, et al. Nonanesthesiologist-administered propofol versus midazolam and propofol, titrated ao moderate sedation, for colonoscopy: a randomized controlled trial. Dig Dis Sci. 2012;57(9):2385–2393. doi: 10.1007/s10620-012-2222-4
   PubMed Web of Science ®Google Scholar
• Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically Ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive care Med. 2022;48(7):811–840. doi: 10.1007/s00134-022-06712-2
   PubMed Web of Science ®Google Scholar
• Dere K, Sucullu I, Budak ET, et al. A comparison of dexmedetomidine versus midazolam for sedation, pain and hemodynamic control, during colonoscopy under conscious sedation. Eur J Anaesthesiol. 2010;27(7):648–652. doi: 10.1097/EJA.0b013e3283347bfe
   PubMed Web of Science ®Google Scholar
• Anger KE. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. Curr Pharm Des. 2013;19(22):4003–4013. doi: 10.2174/1381612811319220009
   PubMed Web of Science ®Google Scholar
• Algharabawy WS, Abusinna RG, AbdElrahman TN. Dexmedetomidine-ketamine versus propofol-ketamine for sedation during upper gastrointestinal endoscopy in hepatic patients (a comparative randomized study). Egypt J Anaesth. 2021;37(1):364–372. doi: 10.1080/11101849.2021.1961428
   Web of Science ®Google Scholar
• Wu W, Chen Q, Zhang LC, et al. Dexmedetomidine versus midazolam for sedation in upper gastrointestinal endoscopy. J Int Med Res. 2014;42(2):516–522. doi: 10.1177/0300060513515437
   PubMed Web of Science ®Google Scholar
• Yin S, Hong J, Sha T, et al. Efficacy and tolerability of sufentanil, dexmedetomidine, or ketamine added to propofol-based sedation for gastrointestinal endoscopy in elderly patients: a prospective, randomized, controlled trial. Clin Ther. 2019;41(9):1864–1877. doi: 10.1016/j.clinthera.2019.06.011
   PubMed Web of Science ®Google Scholar
• El Mourad MB, Elghamry MR, Mansour RF, et al. Comparison of intravenous dexmedetomidine-propofol versus ketofol for sedation during awake fiberoptic intubation: a prospective, randomized study. Anesth Pain Med. 2019;9:864–865. doi: 10.5812/aapm.86442
   Google Scholar
• Abbas I, Hassanein A, Mokhtar M. Effect of low dose ketamine versus dexmedetomidine on gag reflex during propofol based sedation during upper gastrointestinal endoscopy. a randomized controlled study. Egypt J Anaesth. 2017;33(2):165–170. doi: 10.1016/j.egja.2017.01.003
   Web of Science ®Google Scholar
• Goudra B, Gouda G, Mohinder P. Recent developments in drugs for gi endoscopy sedation. Dig Dis Sci. 2020;65(10):2781–2788. doi: 10.1007/s10620-020-06044-5
   PubMed Web of Science ®Google Scholar
• Hayakawa-Fujii Y, Takada M, Ohta S, et al. Hemodynamic stability during induction of anesthesia and tracheal intubation with propofol plus fentanyl, ketamine, and fentanyl-ketamine. J Anesth. 2001;15(4):191–196. doi: 10.1007/s005400170001
   PubMedGoogle Scholar
• Koruk S, Koruk I, Arslan AM, et al. Dexmedetomidine or midazolam in combination with propofol for sedation in endoscopic retrograde cholangiopancreatography: a randomized double blind prospective study. Wideochir Inne Tech Maloinwazyjne. 2020;15(3):526–532. doi: 10.5114/wiitm.2020.95066
   PubMedGoogle Scholar
• El-Hamamsy M, Sadek S, Ahmed AA, et al. Anaesthesia in paediatric patients undergoing bronchoscopy: comparison between dexmedetomidine/propofol, and midazolam/propofol. AustJ J Basic Appl Sci. 2009;3:2111–2117.
   Google Scholar
• Hashiguchi K, Matsunaga H, Higuchi H, et al. Dexmedetomidine for sedation during upper gastrointestinal endoscopy. Gastrointest Endosc. 2008;20(4):178–183. doi: 10.1111/j.1443-1661.2008.00803.x
   Google Scholar
• Funai Y, Pickering AE, Uta D, et al. Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: an in vivo patch-clamp analysis of analgesic mechanisms. Pain. 2014;155(3):617–628. doi: 10.1016/j.pain.2013.12.018
   PubMed Web of Science ®Google Scholar